Protocol Approval Delays Driving Trial Start-Up Time Drag
Definition
Prolonged IRB/IACUC approval and site activation processes delay trial initiation by weeks to months, incurring daily operational costs without revenue generation. Average site activation takes 13-25 weeks, with interventions showing potential 45% reduction.[2]
Key Findings
- Financial Impact: $55,716 per day Phase III trial delay; ~$390,000 per delayed week per site
- Frequency: Recurring per trial start-up cycle
- Root Cause: Complex administrative coordination involving contracts, feasibility, and ethics reviews
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Biotechnology Research.
Affected Stakeholders
CRO Start-Up Managers, Site Principal Investigators, Sponsor Finance Teams
Deep Analysis (Premium)
Financial Impact
$10,000-$50,000 in grant milestone delay penalties; Potential loss of future grant funding if multiple delays occur; Staff time spent managing funder communications and compliance explanations β’ $390,000 per delayed week β’ $390,000 per delayed week Γ 2-3 weeks = $780,000 to $1,170,000 per resubmit
Current Workarounds
Email alerts to sponsors, manual risk log in Excel, verbal escalation β’ Email chains, manual document tracking, in-person lab meetings β’ Email chains, shared Google Docs for protocol tracking, manual status monitoring via IRB portal
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Evidence Sources:
Related Business Risks
High IRB/Ethics Committee Fees and Site Activation Delays
Idle Resources from Protocol Amendment Cycle Times
Excessive Protocol Amendments in Research Protocol Development
Publish-or-Perish Conflicts with Patent Timing
Civil Money Penalties for ClinicalTrials.gov Non-Compliance in Biotech Trials
Administrative Delays in Licensing Contracts
Request Deep Analysis
πΊπΈ Be first to access this market's intelligence